Gonal-F RFF redi-ject 900 unit 1.44ML
Ended Awarded Last action
- Contract number
- SPE2DR26FNQ9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,686
Award facts
- Contract value 100% obligated
- $2,686.43 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on January 5, 2026, for GONAL-F RFF REDI-JECT 900 Unit 1.44ML with a ceiling value of $2,686.43. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, issued under a non-competitive, non-set-aside procurement. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026 and serves as the company's primary vehicle for supplying medical commodities to military and federal healthcare systems.
This delivery order fulfills pharmaceutical supply needs for the Department of Defense through the Defense Logistics Agency's Medical Supply Chain. GONAL-F is a fertility medication commonly used in military and veteran healthcare systems. The award reflects AmerisourceBergen's established capability to meet federal procurement requirements through its comprehensive IDC with DLA, which authorizes the company to supply an extensive range of pharmaceutical products, specialty medications, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare programs globally, including the Defense Health Agency and U.S. Coast Guard.
Quick answers
Who was awarded contract SPE2DR26FNQ9L?
SPE2DR26FNQ9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 5, 2026.
How much is contract SPE2DR26FNQ9L worth?
The government has obligated $2,686 on SPE2DR26FNQ9L.
Is contract SPE2DR26FNQ9L an order under another contract?
Yes. SPE2DR26FNQ9L is a delivery order under SPE2DR25D1021, an indefinite delivery contract.
Was contract SPE2DR26FNQ9L competed?
The extent of competition for SPE2DR26FNQ9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award